Elavil is the brand name for the tricyclic antidepressant amitriptyline used primarily to manage major depressive disorder. It functions by inhibiting the reuptake of serotonin and norepinephrine in the central nervous system, thereby increasing their availability for neuronal signaling. This dual reuptake blockade leads to enhanced mood regulation and reduced perception of pain through central mechanisms. The medication also exhibits antagonism at several histamine and muscarinic receptors, contributing to its sedative and anticholinergic side effect profile. By modulating these neurotransmitter systems the drug improves affective symptoms and can be beneficial for certain chronic pain conditions. Its pharmacokinetic profile involves hepatic metabolism to active metabolites that prolong therapeutic effect and influence dosing frequency. The overall pharmacological action is thus a combination of neurotransmitter reuptake inhibition and receptor interaction that supports its antidepressant and analgesic uses. Clinical outcomes reflect the net effect of these processes on mood elevation and pain perception reduction.

Elavil is the brand name for the medication amitriptyline. It is prescribed to relieve symptoms of major depressive disorder. The drug works by preventing the reabsorption of serotonin and norepinephrine in the brain. Increased levels of these neurotransmitters enhance mood regulation and emotional stability. Elavil also blocks certain receptors that modulate pain signals and sleep patterns. By affecting these receptors the medication can reduce chronic pain and improve sleep quality. The combined effect of neurotransmitter elevation and receptor modulation produces its therapeutic benefit. This dual action explains how the drug provides relief from depression and associated discomfort.

Elavil may cause drowsiness in many patients. Some individuals report dry mouth as a frequent side effect. Weight gain can occur with prolonged use. Dizziness or lightheadedness is also reported. Constipation is a common gastrointestinal symptom. Blurred vision may be experienced by some users. Sweating can increase during treatment. Sexual dysfunction has been noted in certain cases.

Elavil may cause drowsiness as a frequent side effect. Patients often experience a dry mouth that can be uncomfortable. Some individuals notice weight gain over time. Constipation is another common gastrointestinal reaction. Blurred vision can occur due to its anticholinergic properties. Dizziness or lightheadedness may be reported especially when standing up quickly. Occasionally users experience difficulty with urination.